|
![]() | ![]() ![]() | Log on / register BioMed Central home | Journals A-Z | Feedback | Support |
|
| |||||||||||||||||
Instructions for Emerging Themes in Epidemiology authors |
General information
Submission process Manuscripts must be submitted by one of the authors of the manuscript, and should not be submitted by anyone on their behalf. The submitting author takes responsibility for the article during submission and peer review. To facilitate rapid publication and to minimize administrative costs, Emerging Themes in Epidemiology accepts only online submission. The submission process is compatible with version 3.0 or later of Internet Explorer and Netscape Navigator, and with most other modern web browsers. It can be used from PC, Mac, or Unix platforms. Files can be submitted as a batch, or one by one. The submission process can be interrupted at any time - when users return to the site, they can carry on where they left off. See below for examples of acceptable word processor and graphics file formats. Additional files of any type, such as movies, animations, or original data files, can also be submitted as part of the publication. During submission you will be asked to provide a cover letter. Please use this to explain why your manuscript should be published in the journal and to elaborate on any issues relating to our editorial policies detailed in the instructions for authors. Assistance with the process of manuscript preparation and submission is available from the customer support team (info@biomedcentral.com). We also provide a collection of links to useful tools and resources for scientific authors, on our Tools for Authors page.
Publication and peer review processes
Once an article is accepted, it is published in Emerging Themes in Epidemiology immediately as a provisional PDF file. The paper will subsequently be published in both fully browseable web form, and as a formatted PDF; the article will then be available through Emerging Themes in Epidemiology, BioMed Central and PubMed Central, and will also be included in PubMed. The ultimate responsibility for any decision lies with the Editor-in-Chief, to whom any appeals against rejection should be addressed.
Article-processing charges
Editorial policies Any manuscript submitted to the journal must not already have been published in another journal or be under consideration by any other journal, although it may have been deposited on a preprint server. Manuscripts must not have already been published in any journal or other citable form, with the exception that the journal is willing to consider peer-reviewing manuscripts that are translations of articles originally published in another language. In this case, the consent of the journal in which the article was originally published must be obtained and the fact that the article has already been published must be made clear on submission and stated in the abstract. Manuscripts that are derived from papers presented at conferences can be submitted unless they have been published as part of the conference proceedings in a peer reviewed journal. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party. Authors who publish in Emerging Themes in Epidemiology retain copyright to their work (more information). Correspondence concerning articles published in Emerging Themes in Epidemiology is encouraged . Submission of a manuscript to Emerging Themes in Epidemiology implies that all authors have read and agreed to its content, and that any experimental research that is reported in the manuscript has been performed with the approval of an appropriate ethics committee. Research carried out on humans must be in compliance with the Helsinki Declaration, and any experimental research on animals must follow internationally recognized guidelines. A statement to this effect must appear in the Methods section of the manuscript, including the name of the body which gave approval, with a reference number where appropriate. Informed consent must also be documented. Manuscripts may be rejected if the editorial office considers that the research has not been carried out within an ethical framework, e.g. if the severity of the experimental procedure is not justified by the value of the knowledge gained. Generic drug names should generally be used. When proprietary brands are used in research, include the brand names in parentheses in the Methods section. We ask authors of Emerging Themes in Epidemiology papers to complete a declaration of competing interests, which should be provided as a separate section of the manuscript, to follow the Acknowledgements. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'. Much has been written about competing interests (or conflict of interest, as other journals call it) within scientific research, but the following articles provide some background:
R Smith: Making progress with competing interests. BMJ 2002, 325 :1375-1376 CD DeAngelis, PB Fontanarosa, A Flanagin: Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA 2001, 286 :89-9 K Morin, H Rakatansky, FA Riddick Jr, LJ Morse, JM O'Bannon 3rd, MS Goldrich, P Ray, M Weiss, RM Sade, MA Spillman: Managing conflicts of interest in the conduct of clinical trials. JAMA 2002, 287 :78-84 Any 'in press' articles cited within the references and necessary for the reviewers' assessment of the manuscript should be made available if requested by the editorial office. Submission of a manuscript to Emerging Themes in Epidemiology implies that readily reproducible materials described in the manuscript, including all relevant raw data, will be freely available to any scientist wishing to use them for non-commercial purposes. Nucleic acid sequences, protein sequences, and atomic coordinates should be deposited in an appropriate database in time for the accession number to be included in the published article. In computational studies where the sequence information is unacceptable for inclusion in databases because of lack of experimental validation, the sequences must be published as an additional file with the article. Any 'in press' articles cited within the references and necessary for the reviewers' assessment of the manuscript should be made available if requested by the editorial office.
Nucleotide sequences
Protein sequences
Structures
Chemical structures and assays
Microarray data
Computional modeling
Plasmids
BioMed Central is a member of the Committee on Publication Ethics (COPE). Authors who have appealed against a rejection but remain concerned about the editorial process can refer their case to COPE. For more information, visit www.publicationethics.org.uk. BioMed Central endorses the World Association of Medical Editors (WAME) Policy Statement on Geopolitical Intrusion on Editorial Decisions. |
||
| return to top | ||
Preparing main manuscript text
File formats
Users of other word processing packages should save or convert their files to RTF before uploading. Many free tools are available which ease this process. TeX/LaTeX users: We recommend using BioMed Central's TeX template and BibTeX stylefile. If you use this standard format, you can submit your manuscript in TeX format (after you submit your TEX file, you will be prompted to submit your BBL file). If you have used another template for your manuscript, or if you do not wish to use BibTeX, then please submit your manuscript as a DVI file. We do not recommend converting to RTF. Publicon users: Information about Publicon and instructions for authoring in Publicon are available. Note that figures must be submitted as separate image files, not as part of the submitted DOC/ PDF/TEX/DVI file.
Article types
Please read the descriptions of each of the article types, choose which is appropriate for your article and structure it accordingly. If in doubt, your manuscript should be classified as Analytic perspective, the structure for which is described below. In epidemiology, many scientific and other scholarly analyses are not primarily presentations of field or clinical study results. Such articles include epidemiology-based policy analysis, critical analyses of the field and its practices, various contributions to methodology, philosophy, and other perspectives on the field. Such analytic articles are not commentary or debate, and do not fit in the format of a research article either. The Analytic perspective article type provides the flexibility needed to present analytic articles of these kinds. Since the main mission of this journal is to provide an outlet for such articles, it is expected that most submissions will be in this format (though you are encouraged to use any of the other article types if your submission fits it well). Like any scientific analysis, Analytic perspective articles will be reviewed on their scientific merit. They can contain original research results, although the specific results should be secondary to other analysis rather than the primary focus. Teaching articles do not fit well into the standard research article format, so they should be submitted as Analytic perspective articles. They should be identified by titling them in the following format, "Teaching: Descriptive title". Teaching articles should contain a proposed teaching method, tools for carrying out the method, a guide for how to use it, and a recounting of the authors' or others' experience using the method.
Manuscript sections for Analytic perspective articles
Title page
Abstract
Introduction
Analysis
Conclusion
List of abbreviations
Competing interests
Authors are required to complete a declaration of competing interests. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'. When completing your declaration, please consider the following questions: Financial competing interests
Non-financial competing interests Are there any non-financial competing interests (political, personal, religious, ideological, academic, intellectual, commercial or any other) to declare in relation to this manuscript? If so, please specify. If you are unsure as to whether you, or one your co-authors, has a competing interest please discuss it with the editorial office.
Endnotes
Authors' contributions
An "author" is generally considered to be someone who has made substantive intellectual contributions to a published study. To qualify as an author one should 1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) have been involved in drafting the article or revising it critically for important intellectual content; and 3) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship. We suggest the following kind of format (please use initials to refer to each author's contribution): AB carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. JY carried out the immunoassays. MT participated in the sequence alignment. ES participated in the design of the study and performed the statistical analysis. FG conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript. All contributors who do not meet the criteria for authorship should be listed in an acknowledgments section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support.
Acknowledgements
References
Only articles and abstracts that have been published or are in press, or are available through public e-print/preprint servers, may be cited; unpublished abstracts, unpublished data and personal communications should not be included in the reference list, but may be included in the text. Obtaining permission to quote personal communications and unpublished data from the cited author(s) is the responsibility of the author. Journal abbreviations follow Index Medicus/MEDLINE. Citations in the reference list should contain all named authors, regardless of how many there are. We encourage authors to use a recent version of EndNote (version 5 and above) or Reference Manager (version 10) when formatting their reference list, as this allows references to be automatically extracted. Authors submitting articles in EndNote 5 or higher or Reference Manager 10 format will save $50 on the $ Further details about EndNote and Reference Manager are available on the BioMed Central site, including information about how to upgrade. Style files that conform to the BioMed Central style are available for EndNote and Reference Manager. Users of other reference management programs should be able to select other journal styles that output a numeric list styled similarly to the guide below. Examples of the Emerging Themes in Epidemiology reference style are shown below. Please take care to follow the reference style precisely; references not in the correct style may be retyped, necessitating tedious proofreading.
Links
Emerging Themes in Epidemiology reference style
Article within a journal
Article within a journal supplement
In press article
Published abstract
Article within conference proceedings
Book chapter, or article within a book
Whole issue of journal
Whole conference proceedings
Complete book
Monograph or book in a series
Book with institutional author
PhD thesis
Link / URL
|
||
| return to top | ||
|
|
Preparing illustrations and figuresFigures should be provided as separate files and should not be included in the main text of the submitted manuscript. Each figure should comprise only a single file. There is no charge for the use of color. Please read our figure preparation guidelines for detailed instructions on maximising the quality of your figures.
Formats
Figure
legends
Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce figures or tables that have previously been published elsewhere. |
|
| return to top | ||
Preparing tablesEach table should be numbered in sequence using Arabic numerals (i.e. Table 1, 2, 3 etc.). Tables should also have a title that summarizes the whole table, maximum 15 words. Detailed legends may then follow, but should be concise. Smaller tables considered to be integral to the manuscript can be pasted into the end of the document text file, in portrait format (note that tables on a landscape page must be reformatted onto a portrait page or submitted as additional files). These will be typeset and displayed in the final published form of the article. Such tables should be formatted using the 'Table object' in a word processing program to ensure that columns of data are kept aligned when the file is sent electronically for review; this will not always be the case if columns are generated by simply using tabs to separate text. Commas should not be used to indicate numerical values. Color and shading should not be used. Larger datasets can be uploaded separately as additional files. Additional files will not be displayed in the final, published form of the article, but a link will be provided to the files as supplied by the author. Tabular data provided as additional files can be uploaded as an Excel spreadsheet (.xls) or comma separated values (.csv). As with all files, please use the standard file extensions. |
||
| return to top | ||
Preparing additional filesAlthough Emerging Themes in Epidemiology does not restrict the length and quantity of data in a paper, there may still be occasions where an author wishes to provide data sets, tables, movie files, or other information as additional information. These files can be uploaded using the 'Additional Material files' button in the manuscript submission process. The maximum file size for additional files is 20 MB each, and files will be virus-scanned on submission. Any additional files will be linked into the final published article in the form supplied by the author, but will not be displayed within the paper. They will be made available in exactly the same form as originally provided. If additional material is provided, please list the following information in a separate section of the manuscript text, immediately following the tables (if any):
Additional datafiles should be referenced explicitly by file name within the body of the article, e.g. 'See additional file 1: Movie1 for the original data used to perform this analysis'.
Formats and uploading
As with figure files, files should be given the standard file extensions. This is especially important for Macintosh users, since the Mac OS does not enforce the use of standard extensions. Please also make sure that each additional file is a single table, figure or movie (please do not upload linked worksheets or PDF files larger than one sheet).
Mini-websites
|
||
| return to top | ||
Style and language
General
Gene names should be in italic, but protein products should be in plain type. There is no explicit limit on the length of articles submitted, but authors are encouraged to be concise. There is no restriction on the number of figures, tables or additional files that can be included with each article online. Figures and tables should be sequentially referenced. Authors should include all relevant supporting data with each article. Emerging Themes in Epidemiology will not edit submitted manuscripts for style or language; reviewers may advise rejection of a manuscript if it is compromised by grammatical errors. Authors are advised to write clearly and simply, and to have their article checked by colleagues before submission. In-house copyediting will be minimal. Non-native speakers of English may choose to make use of a copyediting service.
Help and advice on scientific writing
Abbreviations
Units
Last revised: 3 October 2005 |
||
| return to top |
|
|
| © 1999-2008 BioMed Central Ltd unless otherwise stated < info@biomedcentral.com > Terms and conditions |